首页|哌啶酸氧化酶对肝癌细胞增殖、凋亡、迁移和侵袭的影响

哌啶酸氧化酶对肝癌细胞增殖、凋亡、迁移和侵袭的影响

扫码查看
目的 研究哌啶酸氧化酶(pipecolic acid oxidase,PIPOX)对肝癌细胞增殖、凋亡、迁移和侵袭的影响.方法 通过免疫组织化学染色法(以下简称免疫组化法)和癌症基因组图谱数据库分析PIPOX在肝癌组织和配对癌旁组织中的表达水平,以及PIPOX表达水平与肝癌患者生存预后之间的关系.构建稳定过表达PIPOX或敲除PIPOX的肝癌细胞系,采用CCK-8和EdU实验检测肝癌细胞的增殖能力;采用细胞凋亡检测实验检测肝癌细胞的凋亡情况;采用Transwell实验检测肝癌细胞的迁移和侵袭能力.构建裸鼠皮下成瘤模型和肿瘤肺转移模型进一步验证PIPOX在体内对肝癌生长和转移的影响.最后,通过实时荧光定量聚合酶链式反应(real-time quantitative polymerase chain reaction,RT-qPCR)和蛋白质免疫印迹法检测肝癌细胞中上皮-间质转化(epithelial-mesenchymal transition,EMT)过程相关标志物的表达水平.结果 免疫组化法和癌症基因组图谱数据库分析结果均显示,与配对癌旁组织相比,肝癌组织中的PIPOX表达水平更低(P<0.05),且预后分析结果显示,与PIPOX高表达组的肝癌患者相比,PIPOX低表达组的肝癌患者呈现了更短的总生存期(P<0.05)和无病生存期(P<0.05).细胞实验结果表明,PIPOX可以显著抑制肝癌细胞的迁移和侵袭能力(P<0.05),但对肝癌细胞的增殖和凋亡情况没有显著影响(P>0.05).动物实验也同样证实,PIPOX可以显著抑制肝癌的肺转移(P<0.05),但对肝癌的生长没有显著影响(P>0.05).最后,RT-qPCR和蛋白质免疫印迹检测结果表明,PIPOX可以促进上皮细胞标志物E-钙粘蛋白的表达(P<0.05),并抑制间质细胞标志物(N-钙粘蛋白、波形蛋白及锌指转录因子1)的表达(P<0.05).结论 PIPOX可以抑制肝癌细胞的迁移和侵袭能力,其机制可能与抑制细胞EMT过程相关.而PIPOX对肝癌细胞的增殖和凋亡情况无显著影响.
Effects of pipecolic acid oxidase on proliferation,apoptosis,migration and invasion of primary liver cancer cells
Objective To investigate the effects of pipecolic acid oxidase(PIPOX)on the proliferation,apoptosis,migration and invasion of primary liver cancer cells.Methods Immunohistochemical staining and analysis of The Cancer Genome Atlas(TCGA)database were used to examine the PIPOX expression levels in liver cancer tissues and paired adjacent normal tissues,and studied their relationship with patient prognosis.Liver cancer cell lines stably overexpressing or knocking out PIPOX were constructed to explore PIPOX's impact on liver cancer cell proliferation,apoptosis,migration and invasion by conducting in vitro functional experiments such as CCK-8,EdU,apoptosis detection,and Transwell assays.In vivo,nude mice subcutaneous tumor models and lung metastasis models were used to verify PIPOX's effect on liver cancer growth and metastasis.Real-time quantitative polymerase chain reaction(RT-qPCR)and western blot were both employed to detect the expression of epithelial-mesenchymal transition(EMT)markers in liver cancer cells.Results Immunohistochemical staining and TCGA database analysis revealed that PIPOX expression was significantly lower in liver cancer tissues compared to paired adjacent normal tissues(P<0.05).Prognostic analysis indicated shorter overall survival and disease-free survival in PIPOX low expression group(P<0.05).In vitro gain-and loss-of-function experiments showed that PIPOX significantly inhibited liver cancer cell migration and invasion(P<0.05),while having no significant effects on their proliferation and apoptosis(P>0.05).Animal experiments also confirmed that PIPOX significantly inhibited liver cancer lung metastasis(P<0.05),but had no significant effects on tumor growth(P>0.05).Finally,RT-qPCR and western blot results revealed that PIPOX promoted the expression of the epithelial marker E-cadherin(P<0.05)and inhibited the expression of mesenchymal markers(N-cadherin,vimentin,Snail)(P<0.05).Conclusions PIPOX significantly inhibits liver cancer cell migration and invasion,potentially via suppressing the EMT process.However,PIPOX does not significantly affect liver cancer cell proliferation and apoptosis.

pipecolic acid oxidaseprimary liver cancerproliferationapoptosismigration and invasion

吕悦、冯旭萍、黄腾达、袁克非、曾勇

展开 >

四川大学华西医院肝脏外科研究室(成都 610041)

哌啶酸氧化酶 原发性肝癌 增殖 凋亡 迁移和侵袭

2024

中国普外基础与临床杂志
四川大学华西医院

中国普外基础与临床杂志

CSTPCD
影响因子:0.858
ISSN:1007-9424
年,卷(期):2024.31(12)